name | 王金老 |
sex | male
|
age | 70 岁 |
hospital number | 843593 |
height | 175 cm |
weight | 70 kg |
BSA | 1.85 m2 |
APACHEⅡ | 38 分 |
Infection source | abdominal
/blood
|
date | 2017.7.2 年/月/日 |
Sequential Organ Failure Assessment | 15 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | |
yes
|
|
yes
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
比阿培南0.6 bid |
|
vasoactive agent | norepinephrine
|
120 min |
|
140 min |
|
420 min |
Temperature | 36.5 ℃ |
Heart Rate | 141 次/分 |
Breath | 19 次/分 |
Systolic pressure (SP) | 155 mmHg |
Diastolic pressure | 85 mmHg |
mean arterial pressure | 109 mmHg |
Pcv-aCO2 | 6.6 mmHg |
DO2 | 274 |
VO2 | 60 |
Ca-vO2 | 31 |
pH value | 7.23 |
PaO2 | 64.5 mmHg |
PaCO2 | 33.6 mmHg |
BE | -12.9 mmol/L(±2.3mmol/L) |
SaO2 | 89.6 % |
Blood lactic acid concentration, LAC | 3.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 92 mmHg |
pH value | 7.19 |
PcvO2 | 43.6 mmHg |
PcvCO2 | 40.2 mmHg |
BE | -12.4 mmol/L |
ScvO2 | 70 % |
Volume of input | 1970 ml |
Volume of output | 1500 ml |
Volume of urine | 1200 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 25 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 12 mmHg |
cardiac output | 1.94 L/min |
cardiac index | 1.05 L/min/m2 |
stroke volume | 13.8 ml |
Stroke Index | 7.4 ml/m2 |
ITBVI | 868 ml/m2 |
GEDVI | 695 ml/m2 |
EVLWI | 11.4 ml/kg |
PVPI | 2.5 |
SVRI | 7396 DSm2/cm5 |
CFI | 2 |
GEF | 5 % |
SVV | 29 % |
PPV | % |
dPmax | 1360 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 2 条 |
LUS | 6 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18 mm |
IVC(expiratory phase) | 11 mm |
respiratory variations of inferior vena cavae diameter | % |
16 mm |
|
13 mm |
|
13 mm |
|
9 mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 23 mm |
IVC(expiratory phase) | 21 mm |
Respiratory variations of inferior vena cavae diameter | % |
21 mm |
|
20 mm |
|
18 mm |
|
17 mm |
Temperature | 35.5 ℃ |
Heart Rate | 117 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 145 mmHg |
Diastolic Pressure | 75 mmHg |
Mean Arterial Pressure | 103 mmHg |
Pcv-aCO2 | 8.1 mmHg |
DO2 | 777 |
VO2 | 204 |
Ca-vO2 | 38 |
PH value | 7.39 |
PaO2 | 68.1 mmHg |
PaCO2 | 36.8 mmHg |
BE | -2.5 mmol/L |
SaO2 | 94.7 % |
Blood Lactic Acid Concentration | 3.9 mmol/L |
Oxygenation index (PaO2/FiO2) | 113 mmHg |
PH value | 7.34 |
PcvO2 | 38 mmHg |
PcvCO2 | 44.9 mmHg |
BE | -1.5 mmol/L |
ScvO2 | 69.8 % |
Volume of input | 3153 ml |
Volume of output | 3188 ml |
Volume of urine | 750 ml |
Ultrafiltration Volume | 2258 ml |
Norepinephrine Dosage | 35 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 15 mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 4 mmHg |
cardiac output | 5.37 L/min |
cardiac index | 2.9 L/min/m2 |
stroke volume | 45.9 ml |
Stroke Index | 24.8 ml/m2 |
ITBVI | 1084 ml/m2 |
GEDVI | 818 ml/m2 |
EVLWI | 13.1 ml/kg |
PVPI | 2.2 |
SVRI | 2727 DSm2/cm5 |
CFI | 3 |
GEF | 12 % |
SVV | 13 % |
PPV | % |
dPmax | 1017 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 3 条 |
LUS | 8 分 |
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 35.6 ℃ |
Heart Rate | 108 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 155 mmHg |
Diastolic Pressure | 79 mmHg |
Mean Arterial Pressure | 109 mmHg |
Pcv-aCO2 | 2.1 mmHg |
DO2 | 553 |
VO2 | 368 |
Ca-vO2 | 75 |
PH value | 7.46 |
PaO2 | 36.5 mmHg |
PaCO2 | 32 mmHg |
BE | -0.7 mmol/L |
SaO2 | 72.2 % |
Blood Lactic Acid Concentration | 6 mmol/L |
Oxygenation index (PaO2/FiO2) | 36 mmHg |
PH value | 7.38 |
PcvO2 | 18 mmHg |
PcvCO2 | 34.1 mmHg |
BE | -4.2 mmol/L |
ScvO2 | 24.1 % |
Volume of input | 6258 ml |
Volume of output | 9414 ml |
Volume of urine | 3100 ml |
Ultrafiltration Volume | 7734 ml |
Norepinephrine Dosage | 125 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 25 mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 4.88 L/min |
cardiac index | 2.64 L/min/m2 |
stroke volume | 45.2 ml |
Stroke Index | 24.4 ml/m2 |
ITBVI | 1048 ml/m2 |
GEDVI | 839 ml/m2 |
EVLWI | 19.7 ml/kg |
PVPI | 3.5 |
SVRI | 2758 DSm2/cm5 |
CFI | 3 |
GEF | 12 % |
SVV | 24.4 % |
PPV | % |
dPmax | 1103 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 5 条 |
LUS | 12 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 21 mm |
IVC(expiratory phase) | 18 mm |
Respiratory variations of inferior vena cavae diameter | % |
18 mm |
|
16 mm |
|
17 mm |
|
15 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 35.2 ℃ |
Heart Rate | 90 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 156 mmHg |
Diastolic Pressure | 77 mmHg |
Mean Arterial Pressure | 108 mmHg |
Pcv-aCO2 | 6.8 mmHg |
DO2 | 502 |
VO2 | 151 |
Ca-vO2 | 40 |
PH value | 7.5 |
PaO2 | 43 mmHg |
PaCO2 | 28.9 mmHg |
BE | 0.5 mmol/L |
SaO2 | 82.4 % |
Blood Lactic Acid Concentration | 5.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 43 mmHg |
PH value | 7.46 |
PcvO2 | 29.6 mmHg |
PcvCO2 | 35.7 mmHg |
BE | 1.6 mmol/L |
ScvO2 | 57.5 % |
Volume of input | 2948 ml |
Volume of output | 4164 ml |
Volume of urine | 200 ml |
Ultrafiltration Volume | 3894 ml |
Norepinephrine Dosage | 158 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 35 mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 2 mmHg |
cardiac output | 3.79 L/min |
cardiac index | 2.05 L/min/m2 |
stroke volume | 42.1 ml |
Stroke Index | 22.8 ml/m2 |
ITBVI | 823 ml/m2 |
GEDVI | 658 ml/m2 |
EVLWI | 34.6 ml/kg |
PVPI | 7.9 |
SVRI | 4137 DSm2/cm5 |
CFI | 3 |
GEF | 14 % |
SVV | 9 % |
PPV | % |
dPmax | 1103 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 9 条 |
LUS | 18 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 25 mm |
IVC(expiratory phase) | 24 mm |
Respiratory variations of inferior vena cavae diameter | % |
21 mm |
|
19 mm |
|
17 mm |
|
16 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 35.5 ℃ |
Heart Rate | 77 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 143 mmHg |
Diastolic Pressure | 73 mmHg |
Mean Arterial Pressure | 100 mmHg |
Pcv-aCO2 | 5.7 mmHg |
DO2 | 703 |
VO2 | 236 |
Ca-vO2 | 47 |
PH value | 7.56 |
PaO2 | 50.5 mmHg |
PaCO2 | 27.9 mmHg |
BE | 3.4 mmol/L |
SaO2 | 89.1 % |
Blood Lactic Acid Concentration | 4.7 mmol/L |
Oxygenation index (PaO2/FiO2) | 40 mmHg |
PH value | 7.5 |
PcvO2 | 31 mmHg |
PcvCO2 | 33.6 mmHg |
BE | mmol/L |
ScvO2 | 59.2 % |
Volume of input | 4555 ml |
Volume of output | 7323 ml |
Volume of urine | 500 ml |
Ultrafiltration Volume | 6373 ml |
Norepinephrine Dosage | 186 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 55 mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 4 mmHg |
cardiac output | 5.07 L/min |
cardiac index | 2.74 L/min/m2 |
stroke volume | 65.8 ml |
Stroke Index | 35.6 ml/m2 |
ITBVI | 1250 ml/m2 |
GEDVI | 1001 ml/m2 |
EVLWI | 34 ml/kg |
PVPI | 6 |
SVRI | 2801 DSm2/cm5 |
CFI | 3 |
GEF | 15 % |
SVV | 10 % |
PPV | % |
dPmax | 842 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 9 条 |
LUS | 20 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 22 mm |
IVC(expiratory phase) | 20 mm |
Respiratory variations of inferior vena cavae diameter | % |
18 mm |
|
16 mm |
|
17 mm |
|
15 mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 35.2 ℃ |
Heart Rate | 93 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 123 mmHg |
Diastolic Pressure | 59 mmHg |
Mean Arterial Pressure | 82 mmHg |
Pcv-aCO2 | 3.9 mmHg |
DO2 | 520 |
VO2 | 180 |
Ca-vO2 | 43.6 |
PH value | 7.5 |
PaO2 | 52.6 mmHg |
PaCO2 | 27.2 mmHg |
BE | -0.7 mmol/L |
SaO2 | 87.8 % |
Blood Lactic Acid Concentration | 2.7 mmol/L |
Oxygenation index (PaO2/FiO2) | 89 mmHg |
PH value | 7.46 |
PcvO2 | 31.4 mmHg |
PcvCO2 | 31.1 mmHg |
BE | -0.7 mmol/L |
ScvO2 | 57.4 % |
Volume of input | 5429 ml |
Volume of output | 8856 ml |
Volume of urine | 550 ml |
Ultrafiltration Volume | 7836 ml |
Norepinephrine Dosage | 220 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 68 mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 5 mmHg |
cardiac output | 4.13 L/min |
cardiac index | 2.23 L/min/m2 |
stroke volume | 24 ml |
Stroke Index | 2.5 ml/m2 |
ITBVI | 788 ml/m2 |
GEDVI | 631 ml/m2 |
EVLWI | 25.9 ml/kg |
PVPI | 6.2 |
SVRI | 2758 DSm2/cm5 |
CFI | 3 |
GEF | 16 % |
SVV | 16 % |
PPV | % |
dPmax | 1109 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 8 条 |
LUS | 16 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 20 mm |
Respiratory variations of inferior vena cavae diameter | % |
IVC(inspiratory phase) | 16 mm |
17 mm |
|
15 mm |
|
16 mm |
|
13 mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 6023 pg/ml |
BNP | pg/ml |
cTNI | 0.068 ng/ml |
Creatine kinase isoenzyme, CKMB | 24 U/L |
Creatinine | 186 umol/L |
Urea nitrogen | 13 mmol/l |
MDRD | 32 ml/min/1.73m2 |
Date of examination | 2017.7.2 yyyy-mm-dd |
WBC | 10.6 X10*9/L |
neutrophilic granulocyte percentage | 96.2 % |
Hb | g/L |
CRP | 29.59 mg/L |
Procalcitonin, PCT | 26.92 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 15 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 9584 pg/ml |
BNP | pg/ml |
cTNI | 0.323 ng/ml |
Creatine kinase isoenzyme, CKMB | 15 U/L |
Creatinine | 104 umol/L |
Urea nitrogen | 9.9 mmol/l |
MDRD | 57 ml/min/1.73m2 |
WBC | 8.7 X10*9/L |
neutrophilic granulocyte percentage | 95.1 % |
Hb | g/L |
CRP | 288.47 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Sequential Organ Failure Assessment | 15 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | 9997 pg/ml |
BNP | pg/ml |
cTNI | 0.073 ng/ml |
Creatine kinase isoenzyme, CKMB | 33 U/L |
Creatinine | 79 umol/L |
Urea nitrogen | 7.5 mmol/L |
MDRD | 75 ml/min/1.73m2 |
WBC | 14.9 X10*9/L |
neutrophilic granulocyte percentage | 96.2 % |
Hb | g/L |
CRP | 267.06 mg/L |
Procalcitonin, PCT | 70.73 ng/ml |
Sequential Organ Failure Assessment | 18 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | yes
|
Plasma infusion | 2400 ml |
platelet transfusion | yes
|
platelet transfusion | 10 U |
APACHEⅡ | 38 分 |
Complication | no
|
prognosis | die
|
28-day mortality | no
|
survival time(day) | 35 天 |
death time | 2017.8.7 yyyy/mm/dd |
diagnosis of death | MODS 肺部感染 呼吸衰竭 心功能不全 |
length of stay | 15 天 |
duration in ICU | 15 天 |
duration of mechanical ventilation | 332 小时 |
ICU expenses | 134947 元 |
Continuous Renal Replacement Therapy | yes
|
Continuous Renal Replacement Therapy | 144 小时 |